Dietary factors in human colorectal cancer

Annual Review of Nutrition

Volumn 19, Issue , 1999, Pages 545-586

  Lipkin, Martin ^a   Reddy, Bandaru ^b   Newmark, Harold ^c   Lamprecht, Sergio A ^a  

^a STRANG CANCER PREVENTION CENTER   (United States)

^b AMERICAN HEALTH FOUNDATION   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Calcium; Calories; Conjugated linoleic acid; Fat; Fiber; Vitamin D

Indexed keywords

CANCER PREVENTION; CANCER RISK; COLON MUCOSA; COLORECTAL CANCER; DIETARY INTAKE; HUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; COLONIC NEOPLASMS; DIET; DIETARY FIBER; ENERGY INTAKE; HUMANS; LINOLEIC ACID; NUTRITION PHYSIOLOGY; RECTAL NEOPLASMS; SPHINGOMYELINS;

RODENTIA;

EID: 0032788194     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.19.1.545     Document Type: Review

References (341)

1. 1. Abe E, Miyura C, Sakagami H, Takeda M, Konno K, et al. 1981. Differentiation of mouse myeloid leukemia cells induced by 1α,25-dihydroxyvitamin D3. Proc. Natl Acad. Sci. USA 78:4990-94
2. rd Int. Symp. Princess Takamatusu Cancer Res. Fund. Princeton, NJ: Princeton Sci.
3. 3. Agranoff BS. 1986. Inositol trisphosphate and related metabolism. Fed. Proc. 45:2627-52
4. 4. Alberts DS, Einspahr J, Rees-McGee S, Ramanujam P, Buller MK, et al. 1990. Effects of dietary wheat bran fiber on rectal epithelial cell proliferation in patients with resection for colorectal cancers. J. Natl. Cancer Inst. 82:1280-85
5. 5. Alberts DS, Ritenbaugh C, Story JA, et al. 1996. Randomized double-blinded, placebo-controlled study of effect of wheat bran fiber and calcium on fecal bile acids in patients with resected adenomatous colon polyps. J. Natl. Cancer Inst. 88:81-92
6. 6. Ammon HP, Wahl MA. 1991. Pharmacology of Curcuma Ionga. Planta Med. 57:1-7
7. 7. Antoshina E, Ostrowski LE. 1997. TGF beta 1 induces growth arrest and apoptosis but not ciliated cell differentiation in rat tracheal epithelial cell cultures. In Vitro Cell Dev. Biol. Anim. 33:212-17
8. 8. Arbman G, Axelson O, Ericsson-Begodzki A-B, Fredriksson M, Nelsson E, Sjodahl R. 1992. Cereal fiber, calcium, and colorectal cancer. Cancer 69:2042-48
9. 9. Archer S, Meng S, Wu J, Johnson J, Tang R, et al. 1998. Butyrate inhibits colon carcinoma cell growth through two distinct pathways. Surgery 124:248-53
10. 10. Augeron C, Laboisse CL. 1984. Emergence of permanently differentiated cell clones in a human colonic cancer cell line after treatment with sodium butyrate. Cancer Res. 44:3961-69
11. 11. Aukema HM, Holub BJ. 1994. Inositol and pyrovoquinone quinone. In Modern Nutrition in Health and Disease, ed. ME Shils, JA Shike, pp. 466-72. Philadelphia: Lea & Febiger
12. 12. Avery A, Paraskeva C, Hall P, Flanders KC, Sporn M, Moorghen M. 1993. TGF-β expression in the human colon: differential immunostaining along the crypt continuum. Br. J. Cancer 68:137-39
13. 13. Barnard JA, Beauchamp RD, Coffey RJ, Moses HL. 1989. Regulation of intestinal epithelial by transforming growth factor type β. Proc. Natl. Acad. Sci. USA 86:1578-83
14. 14. Barnard JA, Warmick G. 1993. Butyrate rapidly induces growth inhibition and differentiation in HT29 cells. Cell Growth Differ. 4:495-501
15. 15. Barnard JA, Warwick GJ, Gold L. 1993. Localization of transforming growth factor-β isoforms in the murine small intestine and colon. Gastroenterology 105:67-73
16. 16. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, et al. 1999. Calcium supplements for the prevention of colorectal adenomas. N. Engl. J. Med. 340:101-7
17. 17. Barsoum GH, Hendrickse C, Winslet MC, Youngs D, Donovan IA, et al. 1992. Reduction of mucosal crypt cell proliferation in patients with colorectal adenomatous polyps by dietary calcium supplementation. Br. J. Surg. 79:581-583
18. 18. Basson MD, Turowski GA, Rashid Z, Hong F, Madri JA. 1996. Regulation of human colonic cell line proliferation and phenotype by sodium butyrate. Dig. Dis. Sci. 41:1986-93
19. 19. Belleli A, Shany S, Levy J, Guberman R, Lamprecht SA. 1992. A protective role of 1,25-dihydroxyvitamin D3 in chemically induced rat colon circinogenesis. Carcinogenexis 13:2293-98
20. 20. Benson JR, Wells BK. 1995. Microsatellite instability and the TGF-β receptor: clues to a growth control pathway. BioEssays 17:1009-12
21. 21. Berridge MJ, Irvine RF. 1984. Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature 312:315-21
22. 22. Bostick RM, Fosdick L, Wood JR, Grambsch P, Grandits GA, et al. 1995. Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients; a randomized double-blinded, placebo-controlled clinical trial. J. Natl. Cancer Inst. 87:1307-15
23. 23. Bostick RM, Potter JD, Fosdick L, Grambsch P, Lumpe JW, et al. 1993. Calcium and colorectal epithelial cell proliferation: a preliminary randomized double-blinded, placebo-controlled clinical trial. J. Natl. Cancer Inst. 85: 132-41
24. 24. Brattain MG, Markowitz SD, Wilson JKV. The type II transforming growth factor-β receptor as a tumor-suppressor gene. Curr. Opin. Oncol. 8:49-63
25. 25. Broquist HP. 1988. Vitamin-like molecules: inositol. In Modern Nutrition in Health and Disease, ed. ME Shils, VR Young, pp. 459-463. Philadelphia: Lea & Febiger
26. 26. Deleted in proof
27. 27. Bull AW, Marnett LJ, Dawe EJ, Nigro ND. 1983. Stimulation of deoxythymidine incorporation in the colon of rats treated intrarectally with bile acids and fats. Carcinogenesis 4:207
28. 28. Bull AW, Soullier BK, Wilson PS, Haydon MT, Nigro ND. 1979. Promotion of azoxymethane intestinal cancer by high-fat diets in rats. Cancer Res 39:4956-59
29. 29. Burkitt DP. 1971. Epidemiology of cancer of the colon and rectum. Cancer 28:3-13
30. 29a. Buset M, Lipkin M, Winawer S, Swaroop S, Friedman E. 1986. Inhibition of human colonic epithelial cell proliferation in vivo and in vitro by calcium. Cancer Res. 46:5426-30
31. 30. Butterworth CE Jr, Hatch K, Macaluso M, Cole P, Sauberlich HE, et al. 1992. Folate deficiency and cervical dysplasia. J. Am. Med. Assoc. 267:528-33
32. 31. Carrol KK. 1986. Dietary fat and cancer: specific action or caloric effect? J. Nutr. 116:1130
33. 32. Caspary WF, Crane RK. 1970. Active transport of myo-inositol and its relation to the sugar transport system in hamster small intestine. Biochem. Biophys. Acta 203:308-16
34. 33. Caygill CP, Hill MJ. 1995. Fish, n-3 fatty acids and human colorectal and breast cancer mortality. Eur. J. Cancer Prev. 4:329-32
35. 34. Caygill CPJ, Charlett A, Hill MJ. 1996. Fat, fish oil and cancer. Br. J. Cancer 74:159
36. 35. Chen RH, Chang TY. 1997. Involvement of caspase family proteases in transforming growth factor-beta-induced apoptosis. Cell Growth Diff. 8:821-27
37. 36. Chmura SJ, Mauceri HJ, Advani S, Heimann R, Beckett MA, et al. 1997. Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition of sphyngomyelinase activation increasing tumor killing by ionizing radiation. Cancer Res. 57:4340-47
38. 37. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, et al. 1996. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 276:1957-63
39. 38. Clemens RS, Reynertson R. 1977. Myoinositol metabolism in diabetes mellitus. Effect of insulin treatment. Diabetes 26:215-21
40. 39. Conney AH, Lysz T, Ferraro T, Abidi TF, Manchand PS, et al. 1991. Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv. Enzym. Regul. 31:385-96
41. 40. Couzy F, Mansourian R, Labate A, Guinchard S, Montagne DH, Dirren H. 1998. Effect of dietary phytic acid on zinc absorption in the healthy elderly, as assessed by serum concentration curve tests. Br. J. Nutr. 80:177-82
42. 41. Craven PA, DeRubertis FR. 1983. Patterns of prostaglandin synthesis and degradation in isolated superficial and proliferative colonic epithelial cells compared to residual colon. Prostaglandins 26:583-89
43. 42. Cravo ML, Mason JB, Dayal Y, Hutchinson M, Smith D, et al. 1992. Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazinetreated rats. Cancer Res. 52:5002-6
44. 43. Culp BR, Titus BJ, Lands WE. 1979. Inhibition of prostaglandin biosynthesis by eicosapentaenoic acid. Prostaglandins Med. 3:269-78
45. 44. Cummings JH. 1981. Shon chain fatty acids in the human colon. Gut 22:763-79
46. 45. DeCosse JJ, Miler HH, Lesser ML. 1989. Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis. J. Natl. Cancer Inst. 81:1290-97
47. 46. DeRubertis FR, Craven PA. 1987. Bile salt stimulation of colonic epithelial proliferation: evidence for the involvement of lipoxygenase products. J. Clin. Invest. 74:1614-24
48. 47. DeRubertis FR, Craven PA. 1987. Relationship of bile salt stimulation of colonic epithelial phospholipid turnover and proliferative activity: role of activation of protein kinasc C. Prev. Med. 16:572-79
49. 48. Derynck R, Feng X-H. 1997. TGF-β signaling. Biochim. Biophys. Acta 1333: F105-50
50. 49. Deschner EE, Maskens AP. 1982. Significance of labeling index and labeling distribution as kinetic parameters in colorectal mucosa of cancer patients and DMH treated animals. Cancer 50:1136-41
51. 50. Deschner EE, Ruperto J, Wong G, Newmark HL. 1991. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 12:1193-96
52. 51. Deschner EE, Ruperto JF, Wong GY, Newmark HL. 1993. The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. Nutr. Cancer 20:199-204
53. 52. De Stefani E, Mendilaharsu M, Denco-Pellegrini H, Ronco A. 1997. Influence of dietary levels of fat, cholesterol, and calcium on colorectal cancer. Nutr. Cancer 29(1):83-89
54. 53. Deleted in proof
55. 54. Dillehay DL, Webb SK, Schmelz EM, Merrill AH. 1994. Dietary sphingomyelin inhibits 1,2-dimethylhydrazine induced colon cancer in CG1 mice. J. Nutr. 124:615-20
56. 55. Duan R-D. 1998. Sphingomyelin hydrolysis in the gut and clinical implications in colorectal tumorigenesis and other gastrointestinal diseases. Scandinavian J. Gastroenterol. 33:673-83
57. 56. DuBois RN, Radhika A, Reddy BS, Entingh AJ. 1996. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110:1259-62
58. 57. Dudejuiya R, Brasitus T. 1986. The role of sphingomyelin synthase and sphingomyelinase in 1,2-dimethylhydrazine-induced lipid alterations in rat colonic plasma membranes. Biochim. Biophys. Acta 863:309-12
59. 58. Dunn SE, Kari FW, French J, Leininger JR. Travlos G, et al. 1997. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation and tumor progression in p53-defident mice. Cancer Res. 57(21):4667-72
60. 59. Earshaw WC. 1995. Nuclear changes in apoptosis. Curr. Opin. Cell Biol. 7:337-43
61. 60. Kastwood GL. 1983. Colon structure. In Colon Structure and Function, ed. L Bustos-Fernandez, pp. 1-14. New York: Plenum Med.
62. 61. Eberhart CE, DuBois RN. 1995. Eicosanoids and gastrointestinal tract. Gastroenterology 109:285-91
63. 62. Kisman JA, Barkla DH, Tutton PJM. 1987. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res. 47:21-25
64. 63. Eisman JA, Koga M, Sutherland RL, Barkla DH, Tutton PJM. 1989. 1,25-Dihydroxyvitamin D3 and the regulation of human cancer cell replication. Proc. Soc. Exp. Biol. Med. 191:221-26
65. 64. Evers BM, Ko TC, Li J, Thompson EA. 1996. Cell cycle protein suppression and p21 induction in differentiating Caco-2 cells. Am. J. Physiol. 271:G722-27
66. 65. Felton JS, Knize MG, Roper M, Fultz E, Shen NH, Turteltaub KW. 1992. Chemical analysis, prevention, and low-level dosimetry of heterocyclic amines from cooked food. Cancer Res. 52:2103-7
67. 12, homocysteine status and DNA damage in young Australian adults. Carcinngenesis 19:1163-71
68. 67. Ferry DR, Smith A, Malkhandi J. Fyfe DW, deTakats PG, et al. 1996. Phase I clinical trial of the flavanoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res. 2:659-68
69. 67a. Food and Nutrition Board. 1997. Dietary Reference Intakes. Washington, DC: Natl. Acad.
70. 68. Frampton RJ, Omond SA, Eisman JA. 1983. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D metabolites. Cancer Res. 43:4443-47
71. 69. Freeman HJ. 1982. Studies on the effects of single fiber sources in the dimethylhydrazine rodent model of human bowel neoplasia. In Dietary Fiber in Health and Disease, ed. GV Vahouny, D Kritchevsky, pp. 287-97. New York: Plenum
72. 70. Fstenbüeger G, Schurich B, Kaina B, Petrusevska RT, Fusening NE, Marks F. 1989. Tumor induction in initiated mouse skin by phorbol esters and methyl-methanesulfonate: correlation between chromosomal damage and conversion ("stage 1 of tumor promotion") in vivo. Carcinogenesis 10:749-52
73. 71. Garland C, Garland FC. 1979. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol. 27:155
74. 72. Garland CF, Garland FC, Gorham ED. 1991. Can colon cancer incidence and death rates be reduced with calcium and vitamin D? Am. J. Clin. Nutr. 54:193-202S
75. 73. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. 1985. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1:307-9
76. 74. Gartel AL, Serfas MS, Gartel M, Goufman E, Wu GS, et al. 1996. P21 (WAF1/CTP1) expression is induced in newly nondividing cells in diverse epithclia and during differentiation of the Caco-2 cells intestinal cell line. Exp. Cell Res. 227:171-81
77. 75. Giardiello FM, Offerhaus GJA, Dubois RN. 1995. The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Eur. J. Cancer 31A:1071-76
78. 76. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. 1995. Alcohol, low-methionine, low folate diets and risk of colon cancer in men. J. Natl. Cancer Inst. 87:265-73
79. 77. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. 1994. Intake of fat meat, and fiber in relation to risk of colon cancer in men. Cancer Res. 54:2930-97
80. 78. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. 1994. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med. 121:241-46
81. 79. Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopolous D, et al. 1993. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J. Natl. Cancer Inst. 85:875-84
82. 80. Glynn SA, Albanes D. 1994. Folate and cancer: a review of the literature. Nutr. Cancer 22:101-19
83. 81. Glynn SA, Albanes D, Pietinen P, Brown CC, Rautalahti M, et al. 1996. Colorectal cancer and folate status: a nested case control study among male smokers. Cancer Epidemiol. Biomarkers Prev. 5:487-94
84. 82. Gomez-Munoz A. 1998. Modulation of cell signalling by ceramides. Biochim. Biophys. Acta 1391:92-109
85. 83. Govindarajan VS. 1980. Turmeric chemistry, technology and quality. Crit. Rev. Food Sci. Nutr. 12:199-301
86. 84. Graham S, Marshall J, Haughey B, Mittelman A, Swanson M, et al. 1988. Dietary epidemiology of cancer of the colon in western New York. Am. J. Epidemiol. 128:490-503
87. 85. Granville DJ, Carthy CM, Hunt DWC, McManus BM. 1998. Apoptosis: molecular aspects of cell death and disease. Lab. Invest. 78:893-913
88. 86. Greene DA, De Jesus PV Jr. Winegrad AI. 1975. Effects of insulin and dietary myo-inositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. J. Clin. Invest. 55:1326-36
89. 87. Gregerson G. 1987. MYO-inositol supplementation. In Diabetic Neuropathy, ed. PJ Dyck, PK Thomas, AK Asbury, AT Winegard, D Porte, pp. 188-89. Philadelphia: Saunders
90. 88. Gregerson G, Bertelson B, Harbo H, Larsen E, Anderson JR, et al. 1983. Oral supplementation of myo-inositol: effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine, and muscle tissue in human diabetics and normals. Acta Neurol. Scand. 67:164-72
91. 89. Gressner AM, Lahme B, Mannherz HG, Polzar B. 1997. TGF-beta-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J. Hepatol. 26:1079-92
92. 90. Grossman J, Mohr S, Lapetina EG, Fiocchi C, Levine AD. 1998. Sequential and rapid activation of caspases during apoptosis of normal intestinal epithelial cells. Am. J. Physiol. 274:G117-24
93. 91. Grunstein M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389:349-52
94. 92. Hague A, Manning AM, Hanlon KA, Huschtscha L, Hart D, Paraskeva C. 1993. Sodium butyrate induces apoptosis in human colonic tumor cell lines in a p53-independcnt pathway-implications for the possible role of dietary fibers in the prevention of large bowel cancer. Int. J. Cancer 55:489-505
95. 93. Hague A, Singh B, Paraskeva C. 1997. Butyrate acts as a survival factor in colonic epithelial cells: further fuel for the in vivo versus in vitro debate. Gastroenterology 112:1036-39
96. 94. Hale AJ, Smith AC, Sutherland LC, Stoneman VEA, Logthome V, et al. 1996. Apoptosis: molecular recognition of cell death. Eur. J. Biochem. 236:1-26
97. 95. Hall PA, Coates PJ, Ansari B, Hopwood D. 1994. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J. Cell Sci. 107:3569-77
98. 96. Hallman M, Bry K, Hoppu K, Lappi M, Pohjavuori M. 1992. Inositol supplementation in premature infants with respiratory distress syndrome. N. Engl. J. Med. 326:1233-39
99. 97. Halsted CH, Gandhi G, Tamura T. 1981. Sulfasalazine inhibits the absorption of folates in ulcerative colitis. N. Engl. J. Med. 305:1513-17
100. 98. Hanif R, Qiap L, Shiff SJ, Rigas B. 1997. Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathways. J. Lab. Clin. Med. 130:576-84
101. 99. Hannah SS, Norman AW. 1994. 1 Alpha,25(OH)2 vitamin D3-regulated expression of the eukaryotic genome. Nutr. Rev. 52:376-82
102. 100. Hansen CM, Maenpaa PH. 1997. EB 1089, a novel vitamin D analog with strong antiproliferative and differentiation-inducing effects on target cells. Biochem. Pharmacol. 54:1173-79
103. 101. Harper JW, Elledge SJ, Kemyomarsi K, Dynlacht B, Tsai LH, et al. 1995. Inhibition of cyclic-dependent kinascs by p21. Mol. Cell Biol. 6:387-400
104. 102. Harper KD, Iozzo RV, Haddard JG. 1989. Receptors for and bioresponses to 1,25-dihydroxy vitamin D in a human colon carcinoma cell line (HT-29). Metabolism 38:1062-69
105. 102a. Hassig CA, Tong JK, Schreiber SL. 1997. Fiber-derived butyrate and the prevention of colon cancer. Chem. and Biol. 4:783-89
106. 103. Haung G, Schmid PC, Ma W-Y, Schmid HHO. 1997. Phosphatidylinositol-3 kinase is necessary for 12-0-tetradecanoylphorbol-13-acetate-induced cell transformation and AP-1 activation. J. Biol. Chem. 272:4187-94
107. 104. Heerdt BG, Houston MA, Augenlicht LH. 1994. Potentiation by specific short chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res. 54:3288-94
108. 105. Hertevig E, Nilssoin A, Bjork J, Hultkrantz R, Duan R-D. 1998. Alkaline sphyngomyelinase activity is markedly decreased in familial adenomatous polyposis and colorectal adenomas: a key factor to the unrestrained cell proliferation? Gastroenterology 114:A610
109. 106. Hertervig E, Nilsson A, Nyberg L, Duan R-D. 1997. Alkaline sphingomyelidase activity is decreased in human colorectal carcinoma. Cancer 79:448-53
110. 107. Holick MF. 1995. Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications. Bone 17:107-11S
111. 108. Hollman PCH, Gaag MVD, Mengelers MJB, van Trijp JMP, De Vries JHM, Katan MB. 1996. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic. Biol. Med. 21:703-7
112. 109. Holub BJ. 1982. The nutritional significance, metabolism and function of myo-inositol and phosphatidylinositol in health and disease. In Advances in Nutritional Research, ed. HH Draper, 4:107-41. New York: Plenum
113. 110. Holub BJ. 1992. The nutritional importance of inositol and the phosphoinositides. N. Engl. J. Med. 326:1285-87
114. 111. Honn KV, Grossi IM, Steinert BW, Chopra H, Onoda J, et al. 1989. Lipoxygenase regulation of membrane expression of tumor cell glycoproteins and subsequent metastasis. Adv. Prostaglandin Thromboxane Leukot. Res. 19:39-43
115. 112. Honn KV, Tang DG. 1992. Adhesion molecules and cancer cell interaction with endothelium and subendothelial matrix. Cancer Metastasis Rev. 11:353-75
116. 113. Howe GR, Benito E, Castellato R, Cornee J, Esteve J, et al. 1992. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J. Natl. Cancer Inst. 84:1887-96
117. 114. Huang C, Ma W-Y, Dong Z. 1996. Requirement of phosphatidylinositol-3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells. Mol. Cell. Biol. 16:6427-35
118. 115. Huang C, Ma W-Y, Hecht S, Dong Z. 1997. Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidyl-inositol-3′kinase.Cancer Res. 57:2873-78
119. 116. Deleted in proof
120. 117. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH. 1994. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 54: 5841-47
121. 118. Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH. 1991. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51:813-19
122. 119. Huang MT, Smart RC, Wong CQ, Conney AH. 1988. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and fenilic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48:5941-46
123. 120. Huang MT, Want ZY, Georgiadis CA, Lasking JD, Cooney AH. 1992. Inhibitory effect of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. Carcinogenesis 13:2183-86
124. 121. Deleted in proof
125. 122. Hursting SD, Thornquist M, Henderson MM. 1990. Types of dietary fat and incidence of cancer at five sites. Prev. Med. 19:242-53
126. 123. Hyman J, Baron JA, Dain BJ, Sandler RS, Haile RW, et al. 1998. Dietary and supplemental calcium and the recurrence of colorectal adenomas. Cancer Epidemiol. Biomarkers Prev. 7:291-95
127. 1 24. Ichikawa H, Sakata T. 1998. Stimulation of epithelial cell proliferation of isolated distal colon of rats by continuous colonic infusion of ammonia or short-chain fatty acids is non additive. J. Nutr. 128:843-47
128. 125. Ip C. 1986. The chemopreventive role of selenium in carcinogenesis. J. Am. Coll. Toxicol. 5:7
129. 126. Ip C, Briggs SP, Haegele AD, Thompson HJ, Storkson J, et al. 1996. The efficacy of conjugated linoleic acid in mammary cancer prevention is independent of the level of type of fat in the diet. Carcinogenesis 17:1045-50
130. 127. Jacobs LR, Lupton JR. 1986. Relationship between colonic luminal pH, cell proliferation, and colon carcinogenesis in 1,2-dimethylhydrazine treated rats fed high fiber diets. Cancer Res. 46:1727-34
131. 128. Jacobs MM, Jansson B, Griffin AC. 1977. Inhibitory effects of selenium on 1,2-dimethylhydrazine and methylazoxymethanol acetate induction of colon tumors. Cancer Lett 2:133-37
132. 129. James S, MacKay A, Colston KW. 1996. Effects of 1,25-dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells. J. Steroid Biochem. Mol. Biol. 58:395-401
133. 130. James SJ, Muskaelishvili L, Gaylor DW, Turturro A, Hart R. 1998. Upregulation of apoptosis with dietary restriction: implications for carcinogenesis and aging. Environ. Health Perspect. 106(Suppl. 1): 307-12
134. 131. Jansson B, Seibert GB, Speer JF. 1975. Gastrointestinal cancer: its geographic distribution and correlation to breast cancer. Cancer 36:2372-79
135. 132. Jensen OM, MacLennan R, Wahrendorf J. 1982. Diet, bowel function, fecal characteristics and large bowel cancer in Denmark and Finland. Nutr. Cancer 4:5-19
136. 133. Jiang MC, Yang Yen HFJ, Yen JJ, Lin JK. 1996. Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr. Cancer 26:111-20
137. 134. Jones B, Gores GJ. 1997. Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine. Am. J. Physiol. 273:G1174-88
138. 134a. Jyonouchi H, Sun S, Iijma K, Wang H, Hecht SS. 1999. Effects of anti-7, 8-dihydroxy-9, 10-epoxy-7,8,9,10-tetrahydrobenzo[α]pyrene on human small airway epithelial cells and the protective effects on myoinositol. Carcinogenesis 20:139-45
139. 135. Kampman E, Giovannuci E, van't Veer P, Rimm E, Stampfer MJ, et al. 1994. Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies. Am. J. Epidemiol. 139:16-29
140. 136. Kargman SL, O'Neil GP, Vickers PJ, Evans JF, Mancini JA, et al. 1995. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55:2556-59
141. 137. Kalo I, Akhmedkhanov A, Koenig K, Toniolo PG, Shore RE, Riboli E. 1997. Prospective study of diet and female colorectal cancer: The New York University Women's Health Study. Nutr. Cancer 28(3):276-81
142. 138. Kato R, Nakadate T, Yamamoto S, Sugimura T. 1983. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition. Carcinogenesis 4:1301-5
143. 139. Klurfeld DM, Weber MM, Kritchevsky D. 1987. Inhibition of chemically induced mammary and colon tumor production by caloric restriction in rats fed increased dietary fat. Cancer Res. 47:2759-62
144. 140. Kroemer G, Petit P, Zamzami N, Vayssiere J, Mignotte B. 1995. The biochemistry of programmed cell death. FASEB J. 9:1277-87
145. 141. Kumar SP, Roy SJ, Tokumo K, Reddy BS. 1990. Effect of different levels of calorie restriction on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res. 50:5761-66
146. 142. Kune G, Kune S, Watson L. 1988. Colorectal cancer risk, chronic illnesses, operations, and medications: case-control results from the Melbourne Colorectal Cancer Study. Cancer Res. 48:4399-404
147. 143. Kune S, Kune GA, Watson LF. 1987. Case-control study of dietary etiological factors: the Melbourne colorectal cancer study. Nutr. Cancer 9:21-42
148. 2 activity. Cancer Lett. 95:181-85
149. 145. Kurokowa M, Lynch K, Podolsky DK. 1987. Effects of growth factors on an intestinal epithelial cell line: transforming growth factor β inhibits proliferation and stimulates differentiation. Biochem. Biophys. Res. Commun. 142:775-82
150. 146. Lamprecht SA, Lifshitz S, Polak-Charcon S, Schwartz B. 1996. Apoptosis in colonic epithelium: a message from the crypt. In Regulation of Cell Growth, Differentiation and Genetics in Cancer, ed. ST Siftosoglu, AC Sartorelli, De Housman, TM Dexter, pp. 166-75. Berlin/Heidelberg: Springer-Verlag
151. 147. Lamprecht SA, Schwartz B, Gliskman A. 1989. Transforming growth factor β in intestinal differentiation and neoplasia. Anticancer Res. 9:1877-82
152. 148. Deleted in proof
153. 149. Lashner BA. 1993. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J. Cancer Res. Clin. Oncol. 119:549-54
154. 150. Lashner BA, Heidenreich PA, Su GL, Kane SV, Hanauer SB. 1989. The effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study. Gastroenterology 97:255-59
155. 151. Layton DW, Bogen KT, Knize MG, Hatch FT, Johnson VM, Felton JS. 1995. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 16(1): 39-52
156. 152. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. 1989. Colorectal cancer and diet in an Asian population - a case-control study among Singapore Chinese. Int. J. Cancer 43:1007-16
157. min/+ mice. Nature Med. 4:1053-57
158. 153. Lewin LM, Beer R. 1973. Prostatic secretion as the source of myo-inositol in human seminal fluid. Fertil. Steril. 24:666-70
159. 154. Liew C, Schut HA, Chin SF, Pariza MW, Dashwood RH. 1995. Protection of conjugated linoleic acids against 2-amino-3-methylimidazol[4,5-f]quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanism. Carcinogenesis 16:3037-43
160. 155. Lifshitz S, Schwartz B, Polak-Charcon S, Benharroch D, Prinsloo I, Lamprecht SA. 1998. Extensive apoptotic death of rat colonic cells deprived of crypt habitat. J. Cell. Physiol. 177:377-86
161. 156. Lipkin M. 1984. Proliferation and differentiation of gastrointestinal cells in normal and disease states. In Physiology of the Digestive Tract, ed. E Jacobson, L Johnson, M Grossman, pp. 145-68. New York: Raven
162. 157. Lipkin M. 1988. Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res. 48:235-45
163. 158. Lipkin M, Newmark HL. 1985. Effect of added dietary calcium in colonic epithelial-cell proliferation in subjects at high risk for familial colon cancer. N. Engl. J. Med. 313:1381-84
164. 159. Litvak DA, Evers BM, Hwang KO, Hellmich MR, Ko TC, Townsend CM. 1998. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21 Waf1/ Cip1 and p27 Kip 1. Surgery 124:161 70
165. 160. Lointier P, Wargovich MJ, Saez S, Levin B, Wildrick DM, Boman BM. 1987. The role of vitamin D3 in the proliferation of a human colon cancer cell line in vitro. Anticancer Res. 7:817-22
166. 161. Lu YP, Chang RL, Huang MT, Conney AH. 1993. Inhibitory effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. Carcinogenesis 14:293-97
167. 162. Lubin F, Rozen P, Arieli B, Farbstein M, Knaani Y, et al. 1997. Nutritional and lifestyle habits and water-fiber interaction in colorectal adenoma etiology. Cancer Epidemiology, Biomarkers & Prev. 6:79-85
168. 163. Lupton JR. 1995. Butyrate and colonic cytokinetics: differences between in vitro and in vivo studies. Eur. J. Cancer Prev. 4:373-78
169. 164. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, et al. 1997. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 57: 1098-102
170. 165. Macquart-Moulin G, Riboli E, Cornee J, Charney B, Berthezene P, Day N. 1986. Case-control study on colorectal cancer and diet in Marseilles. Int. J. Cancer 38:183-91
171. 166. Manach C, Morand C, Texier O, Favier ML, Agullo G, et al. 1995. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J. Nutr. 125:1911-22
172. 167. Manach D, Texier O, Regerat F, Agullo G, Demigne C, Remesy C. 1996. Dietary quercetin is recovered in rat plasma as conjugated derivatives of isohamnetin and quercetin. J. Nutr. Biochem. 7:375-80
173. 168. Manologas SC. 1987. Vitamin D and its relevance to cancer. Anticancer Res. 7:625-38
174. 169. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, et al. 1995. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336-38
175. 170. Markowitz SD, Roberts AB. 1996. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokines Growth Factor Res. 7:93-102
176. 171. Marks AR. 1997. Intracellular calcium-release channels: regulators of cell life and death. Am. J. Physiol. 272(2Pt2): H597-605
177. 172. Martin SJ, Green DR, Cotter TG. 1994. Dieing with death: dissecting the components of the apoptosis machinery. Trends Biochem. Sci. 19:26-30
178. 173. Martinez ME, McPherson RS, Annegers JF, Levin B. 1996. Association of diet and colorectal adenomatous polyps: dietary fiber, calcium, and total fat. Epidemiology 7:264-68
179. 174. Martinez ME, McPherson RS, Annegers JF, Levin B, Glober GA. 1997. A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps. Gastroenterology 113:423-29
180. 175. Martinez ME, Willet WC. 1997. Calcium, vitamin D and colorectal cancer: a review of the epidemiological evidence. Cancer Epidemiol. Biomed. Prev. 7:163-68
181. 176. Mason JB, Levesque T. 1996. Folate: effects on carcinogenesis and the potential for cancer chemoprevention. Oncology 10:1727-36
182. 176a. Mathers JC. 1998. Nutrient regulation of intestinal proliferation and apoptosis. Proc. Nutr. Soc. 57:219-23
183. 177. Mayer JH, Tomlinson DR. 1983. Prevention of defects of anoxal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia 25:433-38
184. 178. McConkey DJ, Nicotera P, Orrenius S. 1994. Signaling and chromatin fragmentation in thymocytes apoptosis. Immunol. Rev. 142:343-63
185. 179. McConkey DJ, Orrenius S. 1997. The role of calcium in the regulation of apoptosis. Biochem. Biophys. Res. Commun. 239:357-66
186. 180. McDonnel SJ, Meyn RE, Robertson LE. 1995. Implications of apoptotic cell death regulation in cancer therapy. Cancer Biol. 6:53-60
187. 181. McIntyre A, Gibson PR, Young GP. 1993. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34:386-91
188. 182. McKeown-Eyssen GE, Bright-See E. 1984. Dietary factors in colon cancer: international relationships. Nutr. Cancer 6:160-70
189. 183. Medina D, Shepherd F. 1981. Selenium-mediated inhibition of 7,12-dimethylbenz(a)anthracene-induced mouse mammary tumorigenesis. Carcinogenesis 2:451-55
190. 184. Merchant T, Diamantis PM, Lauwers G, Haida T, Kasimos JN, et al. 1995. Characterization of malignant colon tumors with 31P nuclear magnetic resonance: phospholipid and phosphatic metabolite profiles. Cancer 76:1715-23
191. 185. Middleton A, Setchell BP. 1972. The origin of inositol in the rete testis fluid of the ram. J. Reprod. Fertil. 30:473-75
192. 186. Mikhailowski R, Shiptz B, Schwartz B, Segal C, Lamprecht SA. 1996. Putative roles of TGF-β in normal and neoplastic murine colon. Regul. Peptide 64:125
193. 187. Miller AB, Howe GR, Jain M, Craib KJ, Harrison L, et al. 1983. Food items and food groups as risk factors in a case-control study of diet and colorectal cancer. Int. J. Cancer 32:155-61
194. 188. Miller JA. 1973. Naturally occurring substances that can induce tumors. In Toxicants Occurring Naturally in Foods, 23:508-49. Washington, DC: Natl. Acad. Sci.
195. 189. Deleted in proof
196. 190. Minghetti PP, Norman AW. 1988. 1,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuitry. FASEB J. 2:3043-53
197. 191. Moore M, Jackson V, Seaky L, Chalkley R. 1979. Comparative studies on highly metabolically active histone acetylsition. Biochim. Biophys. Acta 56:248-60
198. 192. Morris ER. 1986. Phytate and mineral bioavailability. In Phytic Acid, ed. E Graf. pp. 55-77. Minneapolis, MN: Pilatus
199. 193. Nadkarani KM. 1976. Curcuma longa. In India Materia Medica, ed KM Nadkarani, pp. 414-16. Bombay: Popular Prakashan
200. 194. Newmark HL. 1984. A hypothesis for dietary components as blocking agents of chemical carcinogenesis: plant phenolics and pyrrole pigments. Nutr. Cancer 6:58-70
201. 195. Newmark HL. 1987. Plant phenolics as inhibitors of mutational and precarcinogenic events. Can. J. Physiol. Pharmacol. 65:461-66
202. 196. Newmark HL. 1996. Plant phenolics as potential cancer prevention agents. In Dietary Phytochemicals in Cancer Prevention and Treatment, Advances in Experimental Medicine and Biology, 401:25-43. New York: Plenum
203. 197. Newmark HL. 1997. Squalene, olive oil and cancer risk: a review and hypothesis. Cancer Epidemiol. Biomarkers Prev. 6:1101-3
204. 198. Newmark HL, Lipkin M. 1992. Calcium, vitamin D and colon cancer. Cancer Res. 52(Suppl.):2067-70s
205. 199. Newmark HL, Lipkin M, Maheshwari N. 1990. Colonic hyperplasia and hyperproliferation induced by a nutritional stress diet with four components of Western-style diet. J. Natl. Cancer Inst. 82:491-96
206. 200. Newmark HL, Wargovich MJ, Bruce WR. 1984. Colon cancer and dietary fat, phosphate, and calcium: a hypothesis. J. Natl. Cancer Inst. 72:1324-25
207. 201. Nicotera P, Bellomo G, Orenius S. 1992. Calcium-mediated mechanisms in chemically induced cell death. Annu. Rev. Pharmacol. Taxicol. 32:449-70
208. 202. Nigro ND, Bull AW Jr. 1986. Dietary studies of cancer of the large bowel in the animal model. In Dietary Fiber: Basic and Clinical Aspects, ed. GV Vahouny, D. Kritchevsky, pp. 467-69. New York: Plenum
209. 203. Nutter RL, Kettering JD, Apprecio RM, Weeks DA, Gridley DS. 1990. Effects of dietary fat and protein on DMH-induced tumor development and immune responses. Nutr. Cancer 13:141
210. 204. Oakley GP. 1998. Editorial: eat right and take a multivitamin. N. Engl. J. Med. 338:1060-61
211. 205. O'Sullivan KR, Mathias PM, Beattie S, O'Morain C. 1993. Effect of oral calcium supplementation on colonic crypt cell proliferation in patients with adenomatous polyps of the large bowel. Eur. J. Gastroenterol. Hepatol. 5:85-89
212. 206. Paganini-Hill A. 1994. Aspirin and the prevention of colorectal cancer: a review of the evidence. Semin. Surg. Oncol. 10:158-64
213. 207. Panel on Food, Nutrition and the Prevention of Cancer. 1997. Colon, Rectum. In Food, Nutrition and the Prevention of Cancer: A Global Perspective, pp. 216-51. Washington, DC: Am. Inst. Cancer Res.
214. 208. Paradi PW. 1997. Cow's milk fat components as potential anticancer agents. J. Nutr. 127:1055-60
215. 3. Carcinogenesis 9:187-90
216. 210. Pereira MA, Grubbs DJ, Barnes LH, Li H, Olson GR, et al. 1996. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]-anthracene-induced mammary cancer in rats. Carcinogenesis 17:1305-11
217. 211. Peters RK, Pike MC, Garabrant D, Mack TM. 1992. Diet and colon cancer in Los Angeles County. Calif. Cancer Causes Control 3:457-73
218. 212. Philipps WA, St Clair F, Munday AD, Thomas RIS, Mitchell CA. 1998. Increased levels of phosphatidyl 3-kinase activity in colorectal tumors. Cancer 83:41-47
219. 213. Phillips RL. 1975. Role of life-style and dietary habits in risk of cancer among Seventh-Day Adventists. Cancer Res. 35:3513-22
220. 214. Pilch SM. 1987. Physiological Effects and Health Consequences of Dietary Fiber. Bethesda, MD: Life Sci. Res. Off. FASB
221. 215. Platz EA, Giovannuccie E, Rimm EB, Rockett RM, Stampfer MJ, et al. 1987. Dietary fibers and distal colorectal adenoma in men. Cancer Epidemiol. Biomed. Prev. 6:661-70
222. 216. Podolsky DK, Babyatsky MW. 1995. Growth and development of the gastrointestinal tract. In Textbook of Gastroenterology, ed. T. Yamada, pp. 546-77 Philadelphia, PA: Lippincott Company
223. 217. Pollard M, Luckert PH. 1985. Tumorigenic effects of direct and indirect acting chemical carcinogens in rats on a restricted diet. J. Natl. Cancer Inst. 74: 1347-49
224. 218. Pols HAP, Birkenhanger JC, Foekens JA, van Leewen JPTM. 1990. Vitamin D: a modulator of cell proliferation and differentiation. J. Steroid Biochem. Mol. Biol. 37:873-76
225. 219. Potten CS. 1992. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metastasis Rev. 11:179-95
226. 220. Potten CS. 1997. Epithelial cell growth and differentiation. II. Epithelial apoptosis. Am. J. Physiol. 273:G253-57
227. 221. Potten CS, Wilson JW, Booth C. 1997. Regulation of apoptosis in the stem cells of the gastrointestinal epithelium. Stem Cells 15:82-93
228. 222. Potter JD, McMichael AJ. 1986. Diet and cancer of the colon and rectum. A case-control study. J. Natl. Cancer Inst. 76:1573-77
229. 2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol. Rev. 67:1186-235
230. 224. Pritchard DM, Watson AJM. 1996. Apoptosis and gastrointestinal pharmacology. Pharmacol. Ther. 72:149-69
231. 225. Pritchard RS, Baron JA, Gerhardsson de Verdier M. 1996. Dietary Calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. Cancer Epidemiol. Biomarkers Prev. 5:897-900
232. 226. Raff MC. 1992. Social controls in cell survival and cell death. Nature 356:397-400
233. 227. Rao CV, Newmark HL, Reddy BS. 1998. Chemopreventive effect of squalene on colon cancer. Carcinogenesis 19:287-90
234. 228. Rao CV, Rivenson A, Simi B, Reddy BS. 1995. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 55:259-66
235. 229. Rao CV, Simi B, Reddy BS. 1993. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 14:2219-25
236. 2 activities and CO1 metabolite formation during different stage of colon tumor promotion in male F344 rats. Cancer Res. 56:532-37
237. 231. Reddy BS. 1986. Diet and colon cancer: evidence from human and animal model studies. In Diet, Nutrition, and Cancer: A Critical Evaluation, ed. BS Reddy, LA Cohen, 1:47-65. Boca Raton, FL: CRC
238. 232. Reddy BS. 1986. Dietary fat and cancer: specific action or caloric effect. J. Nutr. 116:1132-35
239. 233. Reddy BS. 1992. Animal experimental evidence on macronutrients and cancer. In Macronutrients: Investigating Their Role in Cancer, ed. MS Micozzi, TE Moon, pp 33-54. New York: Dekker
240. 234. Reddy BS. 1994. Chemoprevention of colon cancer by dietary fatty acids. Cancer Metastasis Rev. 13:285-302
241. 235. Reddy BS. 1995. Nutritional factors and colon cancer. Crit. Rev. Food Sci. Nutr. 35:175-90
242. 236. Reddy B, Engle A, Katsifis S, Simi B, Bartram H, et al. 1989. Biochemical epidemiology of colon cancer: effect of types of dietary fiber on fecal mutagens, acid, and neutral sterols in healthy subjects. Cancer Res. 49:4629-35
243. 237. Reddy BS, Engle A, Simi B, Goldman M. 1992. Effect of dietary fiber on colonic bacterial enzymes and bile acids in relation to colon cancer. Gastroenterology 102:1475-82
244. 238. Reddy BS, Maeura Y. 1984. Tumor promotion by dietary fat in azoxymethane induced colon carcinogenesis in female F344 rats: influence of amount and source of dietary fat. J. Natl. Cancer Inst. 72:746-50
245. 239. Reddy BS, Maeura Y, Wayman M. 1983. Effect of dietary corn bran and autohydrolyzed lignin on 3,2′-dimethyl-4-aminobiphenyl-induced intestinal carcinogenesis in male Fischer 344 rats. J. Natl. Cancer Inst. 71:419-23
246. 240. Reddy BS, Maruyama H. 1986. Effect of dietary fish oil on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res. 46:3367-70
247. 241. Reddy BS, Maruyama H. 1986. Effect of different levels of dietary corn oil and lard during the initiation phase of colon carcinogenesis in F344 rats. J. Natl. Cancer. Inst. 77:815-22
248. 242. Reddy BS, Mori H. 1981. Effect of dietary wheat bran and dehydrated citrus fiber on 3,2′-dimethyl-4-aminobiphenyl-induced intestinal carcinogenesis in F344 rats. Carcinogenesis 2:21-25
249. 243. Reddy BS, Mori H, Nicolais M. 1981. Effect of dietary wheat bran and dehydrated citrus fiber on azoxymethane-induced intestinal carcinogenesis in F344 rats. J. Natl. Cancer Inst. 66:553-57
250. 244. Reddy BS, Rivenson A, El-Bayoumy K, Upadhyaya P, Pittman B, Rao CV. 1997. Chemoprevention of colon cancer by synthetic organoselenium compounds, 1,4-phenylenebis(methylene)-selenocyanate and p-methoxy benzyl selenocyanate, in low and/or high fat fed F344 rats. J. Natl. Cancer Inst. 89:506-16
251. 245. Reddy BS, Sharma C, Simi B, Engle A, Laakso K, et al. 1987. Metabolic epidemiology of colon cancer: effect of dietary fiber on fecal mutagens and bile acids in healthy subjects. Cancer Res. 47:644-48
252. 246. Reddy BS, Simi B, Patel N, Aliga C, Rao CV. 1996. Effect of amount and types of dietary fat on intestinal bacterial 7α-dehydroxylase and PI-PLC and colonic mucosal diacylglycerol kinase and PKC activities during different stages of colon tumor development. Cancer Res. 56:2314-20
253. 247. Reddy BS, Sugie S. 1988. Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res. 48:6642-47
254. 248. Reddy BS, Wang CX, Maruyama H. 1987. Effect of restricted caloric intake on azoxymethane-induced colon tumor incidence in male F344 rats. Cancer Res. 47:1226-28
255. 249. Reddy BS, Watanabe K, Weisburger JH. 1977. Effect of high-fat diet on colon carcinogenesis in F344 rats treated with 1,2-dimethylhydrazine, methylazoxymethanol acetate and methylnitrosourea. Cancer Res. 37:4156-59
256. 250. Reed JC. 1998. Dysregulation of apoptosis in cancer. Cancer J. 4 Suppl. 1:S8-14
257. 251. Risio M, Lipkin ML, Newmark HL, Yang K, Rossini FP, et al. 1996. Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in mouse colon. Cancer Res. 56:4910-16
258. 252. Roedinger WEW. 1980. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21:793-98
259. 253. Rosen M, Nystrom L, Wall S. 1988. Diet and cancer mortality in the counties of Sweden. Am. J. Epidemiol. 127:42-49
260. 254. Ross MH, Bras G. 1971. Lasting influence of early caloric restriction on prevalence of neoplasms in the rat. J. Nutr. 47:1095-113
261. 255. Rotruck JT, Pope AL, Ganther HE. 1973. Selenium: biochemical role as a component of glutathione peroxidase. Science 179:588-90
262. 255a. Saez E, Tontonoz P, Nelson MC, Alvarez JGA, Ming UT, et al. 1998. Activators of the nuclear receptor PPAR γ enhance colon polyp formation. Nature Med. 9:1058-61
263. 256. Saied IT, Shamsuddin A. 1998. Upregulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line. Anticancer Res. 18:1479-84
264. 257. Saini KS, Walker NI. 1998. Biochemical and molecular mechanisms regulating apoptosis. Mol. Cell. Biochem. 178:9-25
265. 258. Sakaguchi M, Hiramatsu Y, Takada H, Yamamura M, Hioki K, et al. 1984. Effect of dietary unsaturated and saturated fats on azoxymethane-induced colon carcinogenesis in rats. Cancer Res. 44:1472-77
266. 259. Sandler RS, Lyles CM, Peipins LA, McAuliffe CA, Woosley JT, Kupper LL. 1993. Diet and risk of colorectal adenomas: macronutrients, cholesterol, and fiber. J. Natl. Cancer Inst. 85:884-91
267. 260. Satoskar RR, Shah SJ, Shenoy SG. 1986. Evaluation of antiinflammatory property of curcumin (diferuloylmethane) in patients with postoperative inflammation. Int. J. Clin. Pharmacol. Ther. Toxicol. 24:651-54
268. 261. Scalmati A, Lipkin M, Newmark H. 1992. Calcium, vitamin D and colon cancer. Clin. Appl. Nutr. 2:67-74
269. 262. Deleted in proof
270. 263. Scheppach W. 1994. Effects of short chain fatty acids on gut morphology and function. Gut 35:535-38
271. 264. Scheving L, Jun W-H, Chong K-M, Gardner W, Cope FO. 1998. Dying erythrocytes downregulate signaling pathways converging on ras: rescue by protease inhibition. Am. J. Physiol. 274: C1363-72
272. 265. Schmelz EM, Bushney AS, Dillehay D, Liotta DC, Merrill AH. 1997. Suppression of aberrant crypt foci by synthetic sphingomyelin with saturated or unsaturated sphingolipid backbone. Nutr. Cancer 28:81-85
273. 266. Schmelz EM, Dillehay D, Webb S, Reiter A, Adams J, Merrill AH. 1996. Sphingomyelin consumption suppresses aberrant crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implication for dietary sphingolipids and colon carcinogenesis. Cancer Res. 56:4936-41
274. 267. Schrauzer GN, White DA, Schneider CJ. 1977. Cancer mortality and correlation studies. III. Statistical associates with dietary selenium intakes. Biorg. Chem. 7:23-34
275. 268. Schutz TD, Chew BP, Seaman WR, Luedecke LO. 1992. Inhibitory effect of conjugated dienoic derivatives of linoleic acid and β-carotene on the in vitro growth of human cancer cells. Cancer Lett. 63:125-33
276. 269. Sealy L, Chalkley R. 1978. The effect of sodium butyrate on histone modification. Cell 14:115-21
277. 270. Selhub J, Dhar G, Rosenberg IH. 1978. Inhibition of folate enzymes by sulfasalazine. J. Clin. Invest. 61:221-24
278. 271. Shamberger RJ, Willis CE. 1971. Selenium distribution and human cancer mortality. CRC Crit. Rev. Clin. Lab. Sci. 2:211-21
279. 272. Shamsuddin A, Ullah A, Chakravarthy AK. 1989. Inosilol and inositol hexaphosphate suppress cell proliferation and tumor formation in CD-1 mice. Carcinogenesis 10:1461-63
280. 273. Shamsuddin A, Vucenik I, Cole KE. 1997. IP6: a novel anti-cancer agent. Life Sci. 61:343-54
281. 274. Shamsuddin AM, Ullah A. 1989. Inositol hexaphosphate inhibits large intestinal cancer in F344 rats 5 months following induction by azoxymethane. Carcinogenesis 10:625-26
282. 275. Deleted in proof.
283. 276. Sharma OP. 1976. Antioxidant activity of curcumin and related compounds. Biochem. Pharmacol. 25:1811-12
284. 277. Sherr CJ, Roberts JM. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-53
285. 278. Siavoshian S, Blottiere HM, Cherbut C, Galmiche J-P. 1997. Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells. Biochem. Biophys. Res. Commun. 232:169-72
286. 279. Singh J, Hamid R, Reddy BS. 1997. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res. 57:3465-70
287. 280. Sitrin M. Halline A, Brasitus T. 1990. Effect of dietary calcium and vitamin D on colonocyte proliferation and dimethylhydrazine-induced colon cancer in rats. Gastroenterology 98:A311
288. 281. Slattery ML, Sorenson AW, Ford MH. 1988. Dietary calcium intake as a mitigating factor in colon cancer. Am. J. Epidemiol. 128:504-14
289. 282. Sorenson AW, Slattery ML, Ford MH. 1988. Calcium and colon cancer: a review. Nutr. Cancer 11:135-45
290. 283. Spiegel S, Merrill AH Jr. 1996. Sphingolipid metabolism and cell growth regulation. FASEB J. 10:1388-97
291. 284. Srimal RC, Dhawan BN. 1973. Pharmacology of diferuloylmethane (curcumin), a non-steroidal antiinflammatory agent. J. Pharm. Pharmacol. 25:447-52
292. 285. Steinmetz KA, Kushi LH, Bostick RM, Fulsom AR, Potter JD. 1994. Vegetables, fruit and colon cancer in the Iowa Women's Health Study. Am. J. Epidemiol. 139:1-15
293. 286. Stemmerman GN, Nomura A, Chyou P-H. 1990. The influence of dairy and nondairy calcium on subsite large-bowel cancer risk. Dis. Colon Rectum 33:190-94
294. 287. Suda T, Shinki T, Takashaki N. 1990. The role of vitamin D in bone and intestinal cell differentiation. Annu. Rev. Nutr. 10:195-211
295. 288. Takano S, Matsushima M, Erturk E, Bryan GT. 1981. Early induction of rat colonic epithelial ornithine and S-adenosyl-L-methionine decarboxylase activities by N-methyl-N′-nitro-N-nitrosoguanidine or bile salts. Cancer Res. 41: 624-28
296. 289. Tanaka Y, Bush KK, Eguchi T, Ikekawa N, Taguchi T, et al. 1991. Effects of 1,25-dihydroxyvitamin D3 and its analogs on butyrate-induced differentiation of HT-29 human colonic carcinoma cells and on the reversal of the differentiated phenotype. Arch. Biochem. Biophys. 276:415-23
297. 290. Tannenbaum A, Silverstone A. 1953. Nutrition in relation to cancer. Adv. Cancer Res. 1:451-501
298. 291. Thompson CB. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-62
299. 292. Thompson HJ, Strange R, Schedin PJ. 1992. Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol. Biomarkers Prev. 1:597-602
300. 293. Timer J, Chen YQ, Liu B, Basar R, Taylor JD, et al. 1992. The lipoxygenase metabolite 12(S)-HETE promotes αIIib β3 integrin-mediated tumor-cell spreading on fibronectin. Int. J. Cancer 52:594-603
301. 294. Toda S, Miyase T, Arichi H, Tanizawa H, Takino Y. 1985. Natural antioxidant. III. Antioxidative components isolated from rhizome of Curcuma longa L. Chem. Pharmacol. Bull. 33:1725-28
302. 295. Tonnesen HH. 1992. Chemistry of curcumin and curcuminoids. In Phenolic Compounds in Food and their Effect on Health, ed. CT Ho, CY Lee, MT Haung, 1(506):143-53. Washington, DC: Am. Chem. Soc.
303. 296. Traber PG. 1994. Differentiation of intestinal epithelial cells: lessons from the study of intestine-specific gene expression. J. Lab. Clin. Med. 123:467-77
304. 297. Traber PG. 1997. Epithelial cell growth and differentiation. V. Transcription regulation, development and neoplasia of the intestinal epithelium. Am. J. Physiol. 273:979-81
305. 298. Traber PG, Silberg DG. 1996. Intestine-specific gene transcription. Annu. Rev. Physiol. 59:275-97
306. 299. Trock B, Lanza E, Greenwald P. 1990. Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. J. Natl. Cancer Inst. 82:650-61
307. 300. Trumpt BF, Berezesky K. 1995. Calcium-mediated cell injury and cell death. FASEB J. 9:219-28
308. 301. Tsujii M, DuBois RN. 1995. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell 83:493-501
309. 302. Turner D, Berkel HJ. 1993. Nonsteroidal anti-inflammatory drugs for the prevention of colon cancer. Can. Med. Assoc. J. 149:595-602
310. 303. Ullah A, Shamsuddin AM. 1990. Dose-dependent inhibition of large intestinal cancer by inositol hexaphosphate in D344 rats. Carcinogenesis 11:2219-22
311. 303a. Vanden Heuvel JP. 1998. Peroxisome proliferator-activaled receptors (PPARS) and carcinogenesis. Toxicol. Science 47:1-8
312. 303b. Vanden Heuvel JP. 1999. Peroxisome proliferator-activated receptors: A critical link among fatty acids, gene expression and carcinogenesis. J. Nutr. 129: 575S-80S
313. 304. Vaux D, Strasser A. 1996. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 273:979-81
314. 305. Verma AK, Johnson JA, Gould MN, Taner MA. 1988. Inhibition of 7,12-dimethylbenz(a)anthracene-and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res. 48:5754-58
315. 306. Vucenik I, Sakamoto K, Bansal M, Shamsuddin AM. 1992. Mammary carcinogenesis inhibition by inositol compounds. Proc. Am. Assoc. Cancer Res. 33:166
316. 307. Vucenik I, Yang G-Y, Shamsuddin AM. 1995. Inositol hexaphosphate and inositol inhibit DMBA-induced rat mammary cancer. Carcinogenesis 16:1055-58
317. 307a. Wang CY, Eshleman JR, Willson JK, Markowitz S. 1995. Both transforming growth factor-beta and substrate release are inducers of apoptosis in a human colon adenoma cell line. Cancer Res. 55(21):5101-5
318. 308. Wargovich MF, Isbell G, Shabot M, Winn R, Lanza F, et al. 1992. Calcium supplementation decreases rectal epithelial cell proliferation in subjects with sporadic adenomas. Gastroenterology 103:92-97
319. 309. Wargovich MH, Eng VWS, Newmark HL. 1984. Calcium inhibits the damaging and compensatory proliferation effects of fatty acids on mouse colon epithelium. Cancer Lett. 23:253-58
320. 310. Wargovich MJ, Eng VWS, Newmark HL, Bruce WR. 1983. Calcium ameliorates the toxic effect of deoxycholic acid on colonic epithelium. Carcinogenesis 4:1205-7
321. 311. Watanabe K, Reddy BS, Weisburger JH, Kritchevsky D. 1979. Effect of dietary alfalfa, pectin and wheat bran on azoxymethane or methylnitrosourea-induced colon carcinogenesis in F344 rats. J. Natl. Cancer Inst. 63:151-56
322. 312. Wattenberg L. 1995. Chalones, myo-inositol and other novel inhibitors of pulmonary carcinogenesis. J. Cell. Biochem. 22(Suppl.):162-68
323. 313. Wattenberg L, Estensen RD. 1996. Chemopreventive effects of myo-inositol and dexamethasone on benzo[a]pyrene and 4-(methylnitrosoamino)-1(3-pyridyl)-butanone-induced pulmonary carcinogenesis in female A/J mice. Cancer Res. 56:5132-35
324. 314. Weisburger JH. 1991. Prevention of heterocyclic amine formation in relation to carcinogenesis. In Mutagens in Food: Detection and Prevention, ed. H Hayatsu, pp. 193-203. Boca Raton, FL: CRC
325. 315. Whitehead RH, Young GP, Bhathal PS. 1980. Effects of short chain fatty acids on a new human colon carcinoma cell line (Lim 1215). Gut 27:1457-63
326. 316. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE, et al. 1990. Relation of meat fat and fiber intake to the risk of colon cancer in a prospective study among women. N. Engl. J. Med. 323:1664-72
327. 317. Wilson JW, Potten CD. 1997. Immunohistochemical localization of BA8 and BAFD in the normal and BCL-2 null gastrointestinal tract. Apoptosis 1:183-90
328. 318. Winegrad AI, Greene DA. 1976. Diabetic polyneuropathy: the importance of insulin deficiency, hyperglycemia and alterations in myo-inositol metabolism in its pathogenesis. N. Engl. J. Med. 295:1416-21
329. 319. Deleted in proof
330. 320. Deleted in proof
331. 321. Wright S, Zheng H, Zhong J. 1996. Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 2a kDa apoptotic protease (SP24). FASEB J. 10:325-32
332. 322. Wu AH, Paganini-Hill A, Ross RK, Henderson BE. 1987. Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br. J. Cancer 55:687-94
333. 323. Wyllie AH. 1992. Apoptosis and regulation of cell number in normal and neoplastic tissues: an overview. Cancer Metastasis Rev. 11:95-103
334. 324. Wyllie AH, Duvall E. 1992. Cell injury and death. In Oxford Textbook of Pathology, ed. JOD McGee, PG Isaacson, NA Wright, 1:141-52. Oxford: Oxford Univ. Press
335. 325. Wynder EL, Kajitani T, Ishikawa S, Dodo H, Takano A, et al. 1969. Environmental factors of cancer of the colon and rectum. II. Japanese epidemiological data. Cancer 23:1210-20
336. 326. Xu YX, Pindolia KR, Janakiraman N, Chapman RA, Gautam SC. 1997. Curcumin inhibits IL 1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. Hematopathol. Mol. Hematol. 11:49-62
337. 326a. Yang K, Edelmann W, Fan K, Lau K, Leung D, et al. 1998. Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis. Cancer Res. 58:5713-17
338. 327. Yingling MJ, Wang X-F, Bassing CH. 1995. Signaling by the transforming growth factor-β receptors. Biochim. Biophys. Acta 1242:115-36
339. 328. Yoshida D, Murohashi I, Harashima K. 1996. p53-Independent induction of p21 (WAF1/CIP1) during differentiation of HL-60 cells by tumor necrosis factor alpha. Int. J. Hematol. 65:41-48
340. 329. Zaridze D, Filipchenko V, Kustov V, Serdyuk V, Duffy S, et al. 1992. Diet and colorectal cancer: results of two case-control studies in Russia. Eur. J. Cancer 29A:112-15
341. 330. Zhang Y, Kolesnik R. 1995. Signaling through the sphingomyelin pathway. Endocrinology 136:4157-60